<DOC>
	<DOCNO>NCT00476710</DOCNO>
	<brief_summary>This project compare amount bile acid kinetics overweight obese people normal glucose metabolism , impair glucose tolerance frank type 2 diabetes . We hypothesize bile acid behave differently group . We also explore effect Colesevelam HCl , medicine lower LDL cholesterol bind bile acid , bile acid group . We hypothesize drug may different action bile acid subject different degree abnormal glucose metabolism .</brief_summary>
	<brief_title>Effects Colesevelam HCl On Bile Acid Kinetics</brief_title>
	<detailed_description>Bile acid , synthesize cholesterol liver , play key role digestion solubilize dietary lipid aid absorption digestive tract . While many year bile acid characterize digestive role , recent research indicate bile acid play important role . Because bile acid show act signal pathway affect metabolism , renew interest investigation effect . This study explore potential difference bile acid kinetics base insulin resistance type 2 diabetes baseline . Colesevelam HCl bile acid sequestrant , addition primary role lower serum LDL-C level , secondarily implicate lower blood glucose level . This study explore relationship insulin resistance type 2 diabetes change bile acid pool size kinetics colesevelam treatment . Isotopically label bile acid administer subject treatment colesevelam comparison make bile acid pool size , fractional turnover rate , synthesis rate three study group .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Colesevelam Hydrochloride</mesh_term>
	<mesh_term>Bile Acids Salts</mesh_term>
	<criteria>Have give write informed consent BMI 2535 kg/m^2 , inclusive Normal liver thyroid function No history liver , biliary , intestinal disease Diabetic Subjects Diagnosed Type 2 Diabetes Mellitus HbA1C = 6.710 % Normal Subjects 2 hr OGTT glucose &lt; 140 mg/dL fast glucose &lt; 100 mg/dL TG &lt; 150 mg/dL HDL cholesterol &gt; = 40 mg/dL Impaired Glucose Tolerance Subjects 2 hr OGTT glucose &gt; = 140 &lt; 200 mg/dL T1DM history diabetic ketoacidosis treatment blood pressure lower therapy stable three month screen colesevelam HCl , cholestyramine , colestipol treatment hyperlipidemia within last three month treatment thiazolidinedione ( TZD ) time treatment insulin within past 6 month treatment antibiotic within last 3 month extreme sportsman treatment medication affect liver intestinal function within last 3 month allergic toxic rxn colesevelam HCl history dysphagia , swallow disorder , intestinal motility disorder Serum Triglycerides &gt; 500 mg/dL visit 1 Serum LDLC &lt; 60 mg/dL visit 1 condition therapy investigator believe subject best interest use investigational drug within 30 day screen chronic treatment oral corticosteroid time acute treatment within last three month hyperthyroidism treatment thyroid hormone/levothyroxine</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Type 2 diabetes mellitus</keyword>
	<keyword>Bile acid</keyword>
	<keyword>Stable isotope</keyword>
	<keyword>Colesevelam HCl</keyword>
	<keyword>Impaired Glucose Tolerance</keyword>
</DOC>